The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

• প্রধান লেখক: Rick A. Vreman (লেখক), Lourens T. Bloem (লেখক), Stijn van Oirschot (লেখক), Jarno Hoekman (লেখক), Menno E. van der Elst (লেখক), Hubert GM Leufkens (লেখক), Olaf H. Klungel (লেখক), Wim G. Goettsch (লেখক), Aukje K. Mantel-Teeuwisse (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Kerman University of Medical Sciences, 2022-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

BackgroundThe European Medicines Agency (EMA) aims to resolve uncertainties associated with conditionally approved drugs by imposing post-approval studies. Results from these studies may be relevant for health technology assessment (HTA) organizations. This study investigated the role of regulator-i...